Healthcare & Life Sciences Transactions
News & Insights for Public Companies
- Kirkland Advises Montagu on Acquisition of Johnson Matthey’s Medical Device Components Business
- Kirkland Advises Bristol Myers Squibb on Acquisition of Mirati Therapeutics for up to $5.8 Billion
- Kirkland Advises Eli Lilly on $1.4 Billion Acquisition of POINT Biopharma
- Kirkland Advises Eli Lilly on Acquisition of DICE Therapeutics
- Kirkland Advises Option Care Health in Merger with Amedisys
- Kirkland Represents Eli Lilly on Divesture of BAQSIMI to Amphastar
- Kirkland Counsels Heron Therapeutics on Cooperation Agreement with Rubric Capital and Velan Capital
- Kirkland Advises Oak Street Health, Inc. on $10.6 Billion Sale to CVS Health
- Kirkland Represents SciClone Pharmaceuticals on Voluntary Share Buy-Back Offer